Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
American Journal of Respiratory Cell and Molecular Biology
|
May 26, 1999
Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids
T A Sarafian, J A Magallanes, H Shau, et al.
Chest
|
December 1, 1989
Demand oxygen delivery for patients with restrictive lung disease
R Carter, D Tashkin, B Djahed, et al.
Revista Portuguesa De Pneumologia
|
May 14, 2015
Bronchodilator responsiveness in patients with COPD (data from the UPLIFT trial)
D Tashkin, B Celli, M Decramer, et al.
Revista Portuguesa De Pneumologia
|
May 13, 2015
A 4-year trial of tiotropium in chronic obstructive pulmonary disease (UPLIFT trial)
D Tashkin, B Celli, S Senn, et al.
The American Journal of Medicine
|
July 1, 1981
The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS)
P J Clements, D E Furst, W Cabeen, et al.
Respiratory Medicine
|
July 13, 2010
A one-year trial of tiotropium Respimat plus usual therapy in COPD patients
E D Bateman, D Tashkin, N Siafakas, et al.
Annals of Allergy
|
February 1, 1990
Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol
D G Tinkelman, M L Brandon, M Grieco, et al.
Lancet (London, England)
|
May 30, 2001
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial
D Tashkin, R Kanner, W Bailey, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
American Journal of Respiratory Cell and Molecular Biology
|
May 26, 1999
Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids
T A Sarafian, J A Magallanes, H Shau, et al.
Chest
|
December 1, 1989
Demand oxygen delivery for patients with restrictive lung disease
R Carter, D Tashkin, B Djahed, et al.
Revista Portuguesa De Pneumologia
|
May 14, 2015
Bronchodilator responsiveness in patients with COPD (data from the UPLIFT trial)
D Tashkin, B Celli, M Decramer, et al.
Revista Portuguesa De Pneumologia
|
May 13, 2015
A 4-year trial of tiotropium in chronic obstructive pulmonary disease (UPLIFT trial)
D Tashkin, B Celli, S Senn, et al.
The American Journal of Medicine
|
July 1, 1981
The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS)
P J Clements, D E Furst, W Cabeen, et al.
Respiratory Medicine
|
July 13, 2010
A one-year trial of tiotropium Respimat plus usual therapy in COPD patients
E D Bateman, D Tashkin, N Siafakas, et al.
Annals of Allergy
|
February 1, 1990
Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol
D G Tinkelman, M L Brandon, M Grieco, et al.
Lancet (London, England)
|
May 30, 2001
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial
D Tashkin, R Kanner, W Bailey, et al.
Page
of 2